<DOC>
	<DOC>NCT01072409</DOC>
	<brief_summary>To evaluate the performance of the Nucleus 5 Cochlear Implant System.</brief_summary>
	<brief_title>Clinical Evaluation of the Nucleus 5 Cochlear Implant (CI) System</brief_title>
	<detailed_description>Performance outcomes of newly implanted adult recipients using the Nucleus 5 Cochlear Implant System.</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<criteria>Eighteen years of age or older at the time of the study. Postlinguistic onset of bilateral severetoprofound sensorineural hearing loss Bilateral severetoprofound hearing loss that meets current cochlear implant criteria (&lt;50% openset sentence recognition in quiet scores in the ear to be implanted and &lt;60% in the bestaided condition) English spoken as the primary language. Willingness to participate in and to comply with all requirements of the study Subject may receive bilateral simultaneous cochlear implants. Previous cochlear implant experience Congenital hearing loss (for the purpose of this study, onset prior to 2 yearsofage). Ossification, absence of cochlear development or any other cochlear anomaly that might prevent complete insertion of the electrode array. Normal hearing in one or both ears. Hearing loss of neural or central origin (e.g., deafness due to lesions on the acoustic nerve or central auditory pathway). Active middleear infection. Unwillingness and/or inability of the candidate to comply with all investigational requirements including, but not limited to, study protocol and surgical procedure.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Speech perception ability in the CI alone condition</keyword>
</DOC>